Brucellosis epidemiology and demographics: Difference between revisions

Jump to navigation Jump to search
No edit summary
Line 1: Line 1:
__NOTOC__
__NOTOC__
{{Brucellosis}}
{{Brucellosis}}
{{CMG}}; {{AE}} {{RT}} {{DL}}
{{CMG}}; {{AE}} {{RT}} {{DL}} {{VD}}


==Overview==
==Overview ==
Worldwide, the [[incidence]] of [[Brucellosis]] ranges from a low of 0.01 per 100,000 to high of 200 per 100,000 individuals. [[Case fatality rate]] is less than 2% when untreated. [[Brucellosis]] most commonly affects men in age group between 20 to 45 years old. Areas currently listed as high risk are the Mediterranean Basin (Portugal, Spain, Southern France, Italy, Greece, Turkey, North Africa), South and Central America, Eastern Europe, Asia, Africa, the Caribbean, and the Middle East.<ref name="c">Brucellosis. CDC. http://www.cdc.gov/brucellosis/exposure/index.html.html. Accessed on February 3, 2016</ref>
Worldwide, the [[incidence]] of [[Brucellosis]] ranges from a low of 0.01 per 100,000 to high of 200 per 100,000 individuals. [[Case fatality rate]] is less than 2% when untreated. [[Brucellosis]] most commonly affects men in age group between 20 to 45 years old. Areas currently listed as high risk are the Mediterranean Basin (Portugal, Spain, Southern France, Italy, Greece, Turkey, North Africa), South and Central America, Eastern Europe, Asia, Africa, the Caribbean, and the Middle East.<ref name="c">Brucellosis. CDC. http://www.cdc.gov/brucellosis/exposure/index.html.html. Accessed on February 3, 2016</ref>



Revision as of 18:11, 11 January 2017

Brucellosis Microchapters

Home

Patient Information

Overview

Historical Perspective

Pathophysiology

Causes

Differentiating Brucellosis from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Principles of diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

X-Ray

CT Scan

MRI

Other Diagnostic Studies

Treatment

Medical Therapy

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Brucellosis epidemiology and demographics On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Brucellosis epidemiology and demographics

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Brucellosis epidemiology and demographics

CDC on Brucellosis epidemiology and demographics

Brucellosis epidemiology and demographics in the news

Blogs on Brucellosis epidemiology and demographics

Directions to Hospitals Treating Brucellosis

Risk calculators and risk factors for Brucellosis epidemiology and demographics

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Raviteja Guddeti, M.B.B.S. [2] Danitza Lukac Vishal Devarkonda, M.B.B.S[3]

Overview

Worldwide, the incidence of Brucellosis ranges from a low of 0.01 per 100,000 to high of 200 per 100,000 individuals. Case fatality rate is less than 2% when untreated. Brucellosis most commonly affects men in age group between 20 to 45 years old. Areas currently listed as high risk are the Mediterranean Basin (Portugal, Spain, Southern France, Italy, Greece, Turkey, North Africa), South and Central America, Eastern Europe, Asia, Africa, the Caribbean, and the Middle East.[1]

Epidemiology and Demographics

Epidemiology and Demographics of Brucellosis include:[1][2][3][4][5][6]

Incidence

  • The incidence in different endemic countries varies between 0.01 and 200 per 100,000 individuals.
  • The low incidence reported in known Brucellosis-endemic areas may reflect low levels of surveillance and reporting.[3]
  • Areas currently listed as high risk are the Mediterranean Basin (Portugal, Spain, Southern France, Italy, Greece, Turkey, North Africa), South and Central America, Eastern Europe, Asia, Africa, the Caribbean, and the Middle East.[1]

Case Fatality Rate

Developed Countries

  • Dairy herds in the USA to be certified brucellosis-free are tested at least once a year with the Brucella milk ring test. Many countries such as the US have good surveillance programs.
  • Australia, Canada, France, Belgium, Germany, and many other countries are considered to be brucellosis-free.[5]

Developing Countries

  • Developing countries often do not have safeguards that can help prevent or monitor possible outbreaks, such as pasteurization laws, animal control/slaughter regulations, and Brucellosis surveillance programs.[1]

Demographics

Age

Gender

Race

Reference

  1. 1.0 1.1 1.2 1.3 Brucellosis. CDC. http://www.cdc.gov/brucellosis/exposure/index.html.html. Accessed on February 3, 2016
  2. Mailles A, Garin-Bastuji B, Lavigne JP, Jay M, Sotto A, Maurin M; et al. (2016). "Human brucellosis in France in the 21st century: Results from national surveillance 2004-2013". Med Mal Infect. 46 (8): 411–418. doi:10.1016/j.medmal.2016.08.007. PMID 27717526.
  3. 3.0 3.1 Corbel MJ (1997). "Brucellosis: an overview". Emerg Infect Dis. 3 (2): 213–21. doi:10.3201/eid0302.970219. PMC 2627605. PMID 9204307.
  4. 4.0 4.1 Brucelosis. Commonwealth of Massachusetts. http://www.mass.gov/eohhs/docs/dph/disease-reporting/guide/brucellosis.pdf. Accessed on February 3, 2016
  5. 5.0 5.1 Brucellosis. Wikipedia. https://en.wikipedia.org/wiki/Brucellosis. Accessed on February 3, 2016
  6. 6.0 6.1 6.2 FAO/WHO/OIE Brucellosis in humans and animals. WHO (2006). http://www.who.int/csr/resources/publications/Brucellosis.pdf Accessed on February 3, 2016